Diisobutylaluminum hydride → 1-(4-tert-Butylphenyl)-3-(4-(hydroxymethyl)phenyl)imidazolidin-2-one
Reaction equation
[C:1]([C:5]1[CH:10]=[CH:9][C:8]([N:11]2[CH2:15][CH2:14][N:13]([C:16]3[CH:25]=[CH:24][C:19]([C:20](OC)=[O:21])=[CH:18][CH:17]=3)[C:12]2=[O:26])=[CH:7][CH:6]=1)([CH3:4])([CH3:3])[CH3:2].CC(C[AlH]CC(C)C)C>ClCCl>[C:1]([C:5]1[CH:6]=[CH:7][C:8]([N:11]2[CH2:15][CH2:14][N:13]([C:16]3[CH:17]=[CH:18][C:19]([CH2:20][OH:21])=[CH:24][CH:25]=3)[C:12]2=[O:26])=[CH:9][CH:10]=1)([CH3:4])([CH3:2])[CH3:3]Participants
4
Procedure
A solution of methyl 4-(3-(4-tert-butylphenyl)-2-oxoimidazolidin-1-yl)benzoate (270 mg, 0.77 mmol) in dichloromethane (50 ml) at −78° C. was treated with ml of 1.0 M DIBAL solution in dichloromethane. The resulting solution was stirred cold for 2 hour, then quenched with ml of sat's Rochelle salt solution. The mixture was partitioned between 100 ml dichloromethane and 50 ml of 1 N NaOH. The organic layer was separated, dried and concentrated. The residue was purified on ISCO system (5% methanol in dichloromethane) to give a pure product as a white crystalline (113 mg, 35%): 1H NMR (400 MHz, CDCl3) δ 7.60 (d, 2H), 7.50 (d, 2H), 7.10 (m, 4H), 4.64 (s, 2H), 4.00 (s, 4H), 1.58 (s, 9H).
Workup
- customquenched with ml of sat's Rochelle salt solution
- customThe mixture was partitioned between 100 ml dichloromethane and 50 ml of 1 N NaOH
- customThe organic layer was separated
- customdried
- concentrationconcentrated
- customThe residue was purified on ISCO system (5% methanol in dichloromethane)
- customto give a pure product as a white crystalline (113 mg, 35%)
Sources & evidence
- ORD record
- ord-a45fa349eb6944c2b13435c6cf4cffdd
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07790707B2
Reaction notes
Loading…